请使用支持JavaScript的浏览器!
主营:抗癌化学试剂和激酶抑制剂
℡ 4000-520-616
℡ 4000-520-616
MedKoo/PF-573228newfeatured/25mg/406126
产品编号:406126
市  场 价:¥3000.00
场      地:美国(厂家直采)
产品分类: 蛋白类>多肽>多肽合成>
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$150.00
品      牌: MedKoo
公      司:MedKoo Biosciences, Inc
公司分类:
MedKoo/PF-573228newfeatured/25mg/406126
商品介绍

PF-573228
new
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#:406126

CAS#:869288-64-2

Description:PF-573228 is a potent and selective inhibitor of focal adhesion kinase (FAK) (IC50= 4 nM). Displays 50 - 250-fold selectivity for FAK over other protein kinases. PF573228 was recognized to affect cell adhesion and migration in many types of cells.

Price and Availability

SizePriceShipping out timeQuantity
25mgUSD 150Same day
50mgUSD 250Same day
100mgUSD 450Same day
200mgUSD 750Same day
500mgUSD 1250Same day
1gUSD 1950Same day
2gUSD 39502 Weeks
5gUSD 66502 Weeks
10gUSD 99502 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-23.Prices are subject to change without notice.

PF-573228,purity > 98%, is in stock. The same day shipping out after order is received.

Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 406126Name: PF-573228CAS#: 869288-64-2Chemical Formula: C22H20F3N5O3SExact Mass: 491.12389Molecular Weight: 491.48611Elemental Analysis: C, 53.76; H, 4.10; F, 11.60; N, 14.25; O, 9.77; S, 6.52

Synonym:PF573228; PF 573228; PF-573228; PF573,228; PF 573,228; PF-573,228.

IUPAC/Chemical Name:3,4-Dihydro-6-[[4-[[[3-(methylsulfonyl)phenyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2(1H)-quinolinone

InChi Key:HESLKTSGTIBHJU-UHFFFAOYSA-N

InChi Code:InChI=1S/C22H20F3N5O3S/c1-34(32,33)16-4-2-3-13(9-16)11-26-20-17(22(23,24)25)12-27-21(30-20)28-15-6-7-18-14(10-15)5-8-19(31)29-18/h2-4,6-7,9-10,12H,5,8,11H2,1H3,(H,29,31)(H2,26,27,28,30)

SMILES Code:O=C1NC2=C(C=C(NC3=NC=C(C(F)(F)F)C(NCC4=CC=CC(S(=O)(C)=O)=C4)=N3)C=C2)CC1

Technical Data

Appearance:
White solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:
View CoA: current batch, Lot#BBC50727

QC Data:
View QC data: current batch, Lot# BBC50727

Safety Data Sheet (SDS):
View Safety Data Sheet (SDS)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Additional Information

References

1: Melo TG, Tucci AR, Nogueira AR, Meirelles Mde N,Pereira MC. The involvement of FAK and Src in the invasion ofcardiomyocytes by Trypanosoma cruzi. Exp Parasitol. 2014 Apr;139:49-57.doi: 10.1016/j.exppara.2014.02.008. Epub 2014 Feb 25. PubMed PMID:24582948.

2: Xu B, Ju Y, Song G. Role of p38, ERK1/2, focal adhesion kinase, RhoA/ROCKand cytoskeleton in the adipogenesis of human mesenchymal stem cells. JBiosci Bioeng. 2014 May;117(5):624-31. doi:10.1016/j.jbiosc.2013.10.018. Epub 2013 Dec 9. PubMed PMID: 24331979.

3: Beauséjour M, Thibodeau S, Demers MJ, Bouchard V, Gauthier R,Beaulieu JF, Vachon PH. Suppression of anoikis in human intestinalepithelial cells: differentiation state-selective roles of α2β1, α3β1,α5β1, and α6β4 integrins. BMC Cell Biol. 2013 Dec 1;14:53. doi:10.1186/1471-2121-14-53. PubMed PMID: 24289209.

4: Chan D, Thomas CJ, Taylor VJ, Burke RD. Integrins on eggs: focaladhesion kinase is activated at fertilization, forms a complex withintegrins, and is necessary for cortex formation and cell cycleinitiation. Mol Biol Cell. 2013 Nov;24(21):3472-81. doi:10.1091/mbc.E13-03-0148. Epub 2013 Aug 28. PubMed PMID: 23985318; PubMedCentral PMCID: PMC3814141.

5: Wiemer AJ, Wernimont SA, Cung TD, Bennin DA, Beggs HE, HuttenlocherA. The focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+ Tcell activation. Biochem Pharmacol. 2013 Sep 15;86(6):770-81. doi:10.1016/j.bcp.2013.07.024. Epub 2013 Aug 5. PubMed PMID: 23928188;PubMed Central PMCID: PMC3762933.

6: Kline ER, Shupe J, Gilbert-Ross M, Zhou W, Marcus AI. LKB1 repressesfocal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulateFAK site maturation and directional persistence. J Biol Chem. 2013 Jun14;288(24):17663-74. doi: 10.1074/jbc.M112.444620. Epub 2013 May 1.PubMed PMID: 23637231; PubMed Central PMCID: PMC3682567.

7: Moore SW, Zhang X, Lynch CD, Sheetz MP. Netrin-1 attracts axonsthrough FAK-dependent mechanotransduction. J Neurosci. 2012 Aug22;32(34):11574-85. doi: 10.1523/JNEUROSCI.0999-12.2012. PubMed PMID:22915102; PubMed Central PMCID: PMC3461192.

8: Hori Y, Kashimoto T, Yonezawa T, Sano N, Saitoh R, Igarashi S,Chikazawa S, Kanai K, Hoshi F, Itoh N, Higuchi S. Matrixmetalloproteinase-2 stimulates collagen-I expression throughphosphorylation of focal adhesion kinase in rat cardiac fibroblasts. AmJ Physiol Cell Physiol. 2012 Nov 1;303(9):C947-53. doi:10.1152/ajpcell.00401.2011. Epub 2012 Aug 22. PubMed PMID: 22914642.

9: Tse KW, Lin KB, Dang-Lawson M, Guzman-Perez A, Aspnes GE, BuckbinderL, Gold MR. Small molecule inhibitors of the Pyk2 and FAK kinasesmodulate chemoattractant-induced migration, adhesion and Akt activationin follicular and marginal zone B cells. Cell Immunol. 2012Jan-Feb;275(1-2):47-54. doi: 10.1016/j.cellimm.2012.03.002. Epub 2012Mar 29. PubMed PMID: 22507871.

10: Guessous F, Yang Y, Johnson E, Marcinkiewicz L, Smith M, Zhang Y,Kofman A, Schiff D, Christensen J, Abounader R. Cooperation betweenc-Met and focal adhesion kinase family members in medulloblastoma andimplications for therapy. Mol Cancer Ther. 2012 Feb;11(2):288-97. doi:10.1158/1535-7163.MCT-11-0490. Epub 2011 Dec 21. PubMed PMID: 22188814;PubMed Central PMCID: PMC3277676.

品牌介绍
MedKoo,由化学家和药学家陈清奇博士。北卡罗莱纳州的研究三角区(Research Triangle Park, 简称 RTP ),是一家以研发、生产和销售小分子抗癌化合物为主的医药科技公司,该公司的业务范围主要是为全球所有从事抗癌药物研究和开发的制药公司,高校,研究院所,政府相关机构提供与抗癌药物分子相关的产品、试剂和技术服务。
中文名MedKoo中    文美帝药库医药科技公司创立于2008年总部位于美国东海岸
自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔